Advancing the Science of DE Technologies

The significant improvements in primary patency and target lesion revascularization rates associated with drug-eluting therapies are impacting the decisions of endovascular specialists. Staying on top of these rapid advancements takes established clinical leadership and a commitment to researching and developing innovative therapies that can make a difference in patients’ lives. 

Dr. Miguel Montero-Baker discusses why drug-eluting stent technology is important in SFA interventions.

“We’ve now realized that we need a drug effect to avoid intimal hyperplasia….So we're on the right path.”

Miguel Montero-Baker, MD
Baylor St. Luke’s Medical Center | Houston, TX

Proven Polymer-Based Technology with Proven Biocompatibility

The Eluvia Stent uses the same fluoropolymer as the PROMUS™ and XIENCE™ coronary stents which have a proven history of safety in the body.

Over 20 million plus implants
  1. Data on file at Boston Scientific. Represents total global sales of the PROMUS (Boston Scientific) and XIENCE (Abbott) stents since 2006.
100,000 patients studied in clinical trials
  1. Data on file at Boston Scientific. Represents total population of patients studied in the PROMUS and XIENCE series of clinical trials.
Dr. Robert Lookstein discusses the need to refine drug-eluting technologies in order to improve patency rates.

“It's very, very clear that we're going to need pharmacokinetics to be refined in order to offer improvement in patency, so controlled drug delivery over a longer time frame is clearly a step in the right direction.”

Robert Lookstein, MD
Mount Sinai Medical Center | New York, NY

Antiproliferative Therapies in the SFA

Learn how the biological environment, mechanical challenges and timing of disease progression impact treatment of the SFA and how antiproliferative therapies help reduce the risk of restenosis.

Dr. Jay Kokate discusses the challenges of treating the SFA
Sign Up Today

Stay Up to Date

Receive emails about the latest drug-eluting technology news, innovations and events in your area.
Explore Resources

Explore DE Resources

Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.